The further subgroup analysis involving patients’ medical history did not indicate any substantial impact of T2D, hypertension, hyperlipidemia, and liver fibrosis on systemic chemerin concentrations (Figure 1C–F). The gene discussed is RARRES2; the disease is hyperlipidemia.